D
VistaGen Therapeutics, Inc. VTGN
$3.55 $0.010.28% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -33.40% -54.28% -33.01% 7.96% 369.44%
Total Other Revenue -- -- -- -- --
Total Revenue -33.40% -54.28% -33.01% 7.96% 369.44%
Cost of Revenue -- -- -- -- --
Gross Profit -33.40% -54.28% -33.01% 7.96% 369.44%
SG&A Expenses 7.89% 21.48% 30.03% 34.68% 21.80%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 54.10% 65.65% 53.21% 27.00% -15.19%
Operating Income -56.33% -69.51% -55.86% -27.44% 17.94%
Income Before Tax -68.04% -75.12% -47.50% -11.50% 28.42%
Income Tax Expenses 600.00% 75.00% 128.57% 128.57% -71.43%
Earnings from Continuing Operations -68.05% -75.12% -47.51% -11.52% 28.43%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -68.05% -75.12% -47.51% -11.52% 28.43%
EBIT -56.33% -69.51% -55.86% -27.44% 17.94%
EBITDA -56.45% -69.71% -56.02% -27.51% 17.98%
EPS Basic -16.40% 21.67% 56.13% 72.42% 76.75%
Normalized Basic EPS -16.41% 21.65% 56.13% 72.43% 76.75%
EPS Diluted -16.40% 21.67% 56.13% 72.42% 76.75%
Normalized Diluted EPS -16.41% 21.65% 56.13% 72.43% 76.75%
Average Basic Shares Outstanding 24.15% 59.80% 127.10% 285.39% 255.50%
Average Diluted Shares Outstanding 24.15% 59.80% 127.10% 285.39% 255.50%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --